SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain N501Y variant (rabbit IgG1 Fc-tagged)

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain N501Y variant (rabbit IgG1 Fc-tagged)

CAT N°: 33867
Price:

853.00 725.05

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus, a member of the Betacoronavirus genus, and the causative agent of COVID-19.{53462,53459,53461,55257,55258} The SARS-CoV-2 spike glycoprotein, also known as the surface glycoprotein, is located on the outer envelope of the virion.{53462} It is composed of an S1 and S2 subunit divided by a furin S-cleavage site not found in other SARS-CoVs.{46767,49561} The S1 subunit contains the receptor-binding domain (RBD), which binds to the carboxypeptidase angiotensin-converting enzyme 2 (ACE2), and the S1 and S2 subunits are cleaved by the protease TMPRSS2 to facilitate viral fusion with the host cell membrane.{49542,49536,49558} In this way, ACE2 acts as the functional receptor for SARS-CoV-2. The asparagine-to-tyrosine substitution at position 501 (N501Y) is located within the spike glycoprotein RBD and increases SARS-CoV-2 affinity for human ACE2, which may increase virus transmissibility.{60562} This mutation is shared by three SARS-CoV-2 variants of concern (VOC): B1.1.7, P.1, and B.1.351, originally identified in the United Kingdom, Brazil, and South Africa, respectively. Cayman’s SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain N501Y variant (rabbit IgG1 Fc-tagged) protein can used for ELISA, surface plasmon resonance (SPR), and Western blot (WB) applications.

We also advise you